Literature DB >> 7216454

In vivo evidence that an intact lytic complement pathway is not essential for successful removal of circulating Borrelia turicatae from mouse blood.

K Newman, R C Johnson.   

Abstract

Complement component C5-deficient mice were found to be able to eliminate blood-borne Borrelia turicatae as effectively as normocomplementemic control animals. The absence of C5 and the resultant loss of hemolytic complement activity were confirmed for the deficient mouse strains used. Immunofluorescent staining of complement component C3 on blood-derived borreliae could be readily accomplished as early as 2 days before spirochetal elimination from all mice tested. These observations would suggest that C3 deposition was occurring, even though the terminal lytic steps were blocked in the complement-deficient mice. We propose that spirochetolysis is not requisite for successful removal of borreliae from the circulation of mice.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216454      PMCID: PMC351805          DOI: 10.1128/iai.31.1.465-469.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

2.  The presence of plasma inhibitors during the crisis phenomenon in experimental relapsing fever (Borrelia novyi).

Authors:  O CALABI
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

3.  Relapse phenomena in rats infected with single spirochetes (Borrelia recurrentis var. turicatae).

Authors:  V T SCHUHARDT; M WILKERSON
Journal:  J Bacteriol       Date:  1951-08       Impact factor: 3.490

4.  Characterization of protective antibodies produced in mice infected with Borrelia duttonii.

Authors:  Y Arimitsu; K Akama
Journal:  Jpn J Med Sci Biol       Date:  1973-12

5.  Biology of Borrelia hermsii in Kelly medium.

Authors:  H G Stoenner
Journal:  Appl Microbiol       Date:  1974-10

6.  Immunology of borreliosis in nonhuman primates.

Authors:  O Felsenfeld; R H Wolf
Journal:  Fed Proc       Date:  1975-07

7.  Biosynthesis of a single chain pro-C5 by normal mouse liver mRNA: analysis of the molecular basis of C5 deficiency in AKR/J mice.

Authors:  F Patel; J O Minta
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

8.  Phagocytosis of Borrelia recurrentis by blood polymorphonuclear leukocytes is enhanced by antibiotic treatment.

Authors:  T Butler; M Aikawa; A Habte-Michael; C Wallace
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

10.  Deficiency of the fifth component of complement in mice with an inherited complement defect.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

View more
  17 in total

1.  In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies.

Authors:  A G Barbour; V Bundoc
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 2.  B1b lymphocyte-derived antibodies control Borrelia hermsii independent of Fcα/μ receptor and in the absence of host cell contact.

Authors:  Matthew J Colombo; David Abraham; Akira Shibuya; Kishore R Alugupalli
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae.

Authors:  Harald Gelderblom; Jens Schmidt; Diana Londoño; Yunhong Bai; Jacqueline Quandt; Ron Hornung; Adriana Marques; Roland Martin; Diego Cadavid
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi.

Authors:  J L Schmitz; S D Lovrich; S M Callister; R F Schell
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

Review 5.  Biology of Borrelia species.

Authors:  A G Barbour; S F Hayes
Journal:  Microbiol Rev       Date:  1986-12

6.  Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis.

Authors:  L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Dual role of MyD88 in rapid clearance of relapsing fever Borrelia spp.

Authors:  Devin D Bolz; Rhianna S Sundsbak; Ying Ma; Shizuo Akira; John H Weis; Tom G Schwan; Janis J Weis
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

8.  Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice.

Authors:  Matthew B Lawrenz; R Mark Wooten; James F Zachary; Scott M Drouin; Janis J Weis; Rick A Wetsel; Steven J Norris
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  T-cell-independent elimination of Borrelia turicatae.

Authors:  K Newman; R C Johnson
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice.

Authors:  Christer Larsson; Jenny Lundqvist; Nico van Rooijen; Sven Bergström
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.